Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
Mar. 22 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
Mar. 22 | Nutra Pharma Corporation Announces Management Changes | CI |
Financials (USD)
Sales 2020 | 51.9K | Sales 2021 | 97.74K | Capitalization | 14.65M |
---|---|---|---|---|---|
Net income 2020 | - | Net income 2021 | -13M | EV / Sales 2020 | 238 x |
Net Debt 2020 | 5.24M | Net Debt 2021 | 8.3M | EV / Sales 2021 | 235 x |
P/E ratio 2020 |
-10.3
x | P/E ratio 2021 |
-1.1
x | Employees | 4 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 16-07-26 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Stewart Lonky
BRD | Director/Board Member | 75 | 04-11-04 |
Garry Pottruck
BRD | Director/Board Member | 65 | 09-07-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.0001 | 0.00% | 2,519,500 |
24-04-24 | 0.0001 | 0.00% | 51,094 |
Delayed Quote OTC Markets, April 26, 2024 at 03:27 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 706K | |
+2.46% | 42.75B | |
+47.70% | 41.61B | |
+11.79% | 41.34B | |
-8.83% | 26.59B | |
+7.00% | 25.49B | |
-22.65% | 18.12B | |
+30.67% | 12.24B | |
-1.99% | 11.76B | |
+9.28% | 11B |
- Stock Market
- Equities
- NPHC Stock